S. Venz et al., I-123 IOMAZENIL AND TC-99M-HMPAO IN THE D IAGNOSIS OF FOCAL EPILEPSIES - COMPARISON OF TREATED AND UNTREATED PATIENTS, Nuklearmedizin, 33(1), 1994, pp. 1-7
The purpose of this study was to compare HMPAO- and IMZ-SPECT findings
in treated and untreated patients with focal epilepsies. We examined
20 patients (untreated 13; treated 7). All patients had a normal CT an
d/or MRI scan. In all patients both whole-brain activity and regional
count density (rcd) were evaluated by SPECT Furthermore, the specific
and non-specific binding of IMZ were calculated for each ROI and the r
esults of both, treated and untreated patients were compared. Our data
indicate that the normalized cerebral total binding of IMZ was signif
icantly increased in all regions in the group of treated patients (p <
0.001). In contrast, no difference in the tracer binding was found wit
h HMPAO-SPECT. We conclude that the difference in the IMZ-binding migh
t be due either to exogenous or endogenous factors. In our study IMZ-S
PECT had a higher sensitivity and a lower specificity in the detection
of decreased rcd in areas with EEG findings that indicate an epilepto
genic focus compared with HMPAO-SPECT